Back to BlackRock, Inc. BlackRock, Inc.

PDSBPDSB
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in PDS BIOTECHNOLOGY CORP

BlackRock, Inc. holds 607,639 shares of PDSB (PDS BIOTECHNOLOGY CORP), worth $535,391 as of 2026-Q2. The position was increased (+9.7% shares).

Current Value

$535,391

Current Shares

607,639

Total Value Change

-$317,331

Total Shares Change

+84,497

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
607,639
+9.7%
$535,3910.0%$0.88
18
2026-Q1
Increased
554,048
+6.1%
$335,1990.0%$0.67
17
2025-Q4
Increased
522,211
+0.9%
$401,9980.0%$0.80
16
2025-Q3
Increased
517,519
+0.6%
$522,6940.0%$1.01
17
2025-Q2
Increased
514,391
+5.4%
$684,1390.0%$1.41
18
2025-Q1
Decreased
488,033
-6.7%
$580,7590.0%$1.26
0
2024-Q4
New
523,142
-
$852,7220.0%$1.69
38

Other major holders of PDSB: BlackRock Finance, Inc., TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used